H & H INTL. HDG. upgrades to Neutral based on its reduced risk exposure
The independent financial analyst theScreener just revised the risk rating of H & H INTL. HDG. (HK), active in the Nondurable Household Products industry. As regards its fundamental valuation, the title loses a star(s) and now shows 2 out of 4 stars. Its market behaviour, however, has improved and can be qualified as moderately risky. theScreener believes that the improved risk assessment offsets the loss of a star and merits an overall rating upgrade to Neutral. As of the analysis date February 22, 2022, the closing price was HKD 12.38 and its expected value was estimated at HKD 13.05.Health & Happiness (H&H) International Holdings is an investment holding company. Through its subsidiaries, Co. is mainly engaged in providing pediatric nutritional and baby care products to mothers. As of Dec 31 2014, Co. had four reportable operating segments as follows: infant formulas, which comprises the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers; probiotic supplements, which comprises the production of probiotic supplements; dried baby food and nutrition supplements, whihc comprises the production of dried baby food products; baby care products.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.